Congress delegates are cordially invited to submit abstracts of their scientific work for presentation as a free communication at Euromedlab Munich 2021. An unlimited number of abstracts may be submitted provided the presenting author applies for “full registration”.
Abstracts are welcome in all fields of clinical chemistry, haematology, clinical molecular biology and laboratory medicine, in the broader sense. Free communications are primarily presented via poster. A limited number of abstracts will be selected for oral presentation during symposia. Authors wishing to compete for these oral communication slots should mark the appropriate field on the on-line abstract-submission form.

Abstract Topics

  • Advanced technologies , including new biomarker discovery
  • Analytical technologies and applications
  • Artificial intelligence – Informatics
  • Atherosclerosis, including lipids and other risk markers
  • Audit
  • Autoimmune diseases , including allergy
  • Bioinformatics, including data management
  • Biomarkers in cancer
  • Bone metabolism
  • Cardiovascular diseases, including cardiac markers
  • Case report
  • Clinical Studies – Outcomes
  • Diabetes, obesity, metabolic syndrome
  • Education and Training in Laboratory Medicine
  • Endocrinology, not including diabetes
  • Evidence based medicine, including Guidelines
  • Gastrointestinal diseases, including hepatic and pancreatic diseases
  • Genetic diseases
  • Haematology, including haemostasis
  • Inflammation, vascular biology, endothelium, and oxidative stress
  • Inherited disorders, metabolic disorders and rare diseases
  • Kidney diseases
  • Laboratory and Sports medicine
  • Laboratory Management, Accreditation, Quality Assurance, performance specification
  • Microbiology – Infectious diseases including COVID 19
  • Molecular diagnostics, including epigenetics
  • Neonatal and paediatric laboratory medicine, including prenatal testing
  • Neurological diseases
  • Nutrition, including vitamins and trace elements
  • Personalised Medicine, including pharmacogenetics
  • Point of Care testing, critical care, emergency medicine.
  • Reference intervals and decision limits
  • Total Testing Process, including standardisation, preanalytical process
  • Toxicology, including therapeutic drug monitoring
  • Urinalysis
  • Other

General Information

Deadline for receipt
Abstracts should be submitted by 31st August 2021, 18:30 CET.
Confirmation of receipt
Receipt of the abstract will be acknowledged by e-mail immediately after submission.
Notification of acceptance or rejection
Authors will be notified of acceptance or rejection before 1st October 2021.
Registration
The presenting author of each abstract must register for the congress with “Full Registration”.

General Requirements

The text must be clear, concise, and written in proper English. The content must not have been
previously published in academic journals or subject to peer review. Significant technical information must not be withheld. Abstracts must absolutely contain results. Statements such as “results will be discussed” are not acceptable and will lead to rejection.

How to prepare and submit an abstract

It is important to carefully follow the instructions below. Incorrectly prepared abstracts will be rejected.

  • Abstracts should be prepared off-line in advance;
  • Prepare your abstract on a word processor (such as Microsoft Word);
  • Do not include title, authors’ names and affiliations in the abstract file
  • Tables and figures are not allowed;
  • References are not allowed;
  • When abbreviations are used, spell out the full word at first mention in the text followed by the
    abbreviation in parentheses. Thereafter, use the abbreviation throughout.

When the on-line system requires the abstract to be entered, copy and paste your text.
Abstracts are limited to 2300 characters, spaces included (title, authors’ names and affiliations
excluded). The system will automatically notify you if the abstract exceeds this number of characters.
Title, author(s) and affiliation(s) must be added separately at the appropriate step.

Important notice

Abstract authors are asked to indicate the most suitable topic for presentation of their work and will
also be asked whether they wish apply for an oral presentation during the scientific symposia. In that case, authors must also select the symposium in which they would like to give their presentation.